Criteo vs Thryv
CRTO and THRY side by side, both in business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRTO and THRY compare
Criteo is the larger company, worth 24 times as much as Thryv ($908M against $38.4M).
Criteo grew revenue faster over the last twelve months (0.60% versus −6.2% for Thryv).
Criteo keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with −2.3% at Thryv.
Criteo scores higher on the StockData Score (19 against 10 for Thryv), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRTO | THRY |
|---|---|---|
| Size and price | ||
| Market cap | $908M | $38.4M |
| Share price | $18.54 | $0.864 |
| Change, 1 year | −10.7% | −85.3% |
| Change, 5 years | −52.8% | −97.7% |
| Beta (5Y) | 0.69 | 0.43 |
| Employees | 1,181 | 2,729 |
| StockData Score | ||
| Total score | 19 (better) | 10 |
| Valuation score | 6 (better) | 4 |
| Growth score | 3 (better) | 1 |
| Performance score | 5 (better) | 3 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 7.0× | – |
| P/S | 0.5× | 0.1× (better) |
| P/B | 0.8× | 0.2× (better) |
| EV/EBITDA | 3.3× (better) | 3.8× |
| P/FCF | 4.4× | 1.0× (better) |
| PEG | 0.04 | – |
| FCF yield | 23.0% | 99.3% (better) |
| Fair value | $49.81 | $11.81 |
| Margin of safety | 62.8% | 92.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 0.60% (better) | −6.2% |
| Revenue growth, 5Y average | −1.3% (better) | −6.7% |
| Net income growth (TTM) | 29.6% | – |
| EPS growth (TTM) | 38.9% | – |
| EPS growth, 5Y average | 17.9% (better) | −70.4% |
| Profitability | ||
| Gross margin | 54.0% | 66.1% (better) |
| Operating margin | 10.4% (better) | 4.7% |
| Net margin | 7.4% (better) | −2.3% |
| FCF margin | 10.7% (better) | 5.4% |
| Return on equity | 13.0% (better) | −7.6% |
| Return on invested capital | 17.4% (better) | 5.7% |
| Financial health | ||
| Debt / equity | 0.00 | 1.15 (better) |
| Net debt / EBITDA | – | 3.31 |
| Interest coverage | 82.4× (better) | 1.1× |
| Current ratio | 1.29 (better) | 1.00 |
| Altman Z-score | 2.48 (better) | 0.06 |
| Piotroski F-score | 9 (better) | 7 |
| Dividends and buybacks | ||
| Buyback yield | 16.7% | – |
| Shareholder yield | 16.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 83.9% | 88.0% |
| Held by insiders | 4.0% | 28.9% |
| Insider net buying, 12 months | −$1.5M | $7.4M (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 2.6% | 9.2% |
Go deeper
- CRTO stock overview
- CRTO income statement
- CRTO valuation and score
- THRY stock overview
- THRY income statement
- THRY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.